Walker Neal bought ACRS
February 2, 2026 · Form 4 insider transaction
Walker Neal bought 961,700 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
961,700
Price
$0.00
Total value
N/A
InsiderWalker Neal
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 6, 2026
Shares owned after961,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.